Tag: Clinical Trials
Mission Bio And Onconova Partner To Use Tapestri® Platform Single-Cell DNA Analysis In Clinical...
Mission Bio, the pioneer in targeted single-cell DNA
analysis and precision genomics, and Onconova Therapeutics, have formed a
collaboration to utilize the Mission Bio Tapestri®
Platform for...
Meeting – C-Path and NORD Launch The Rare Disease Cures Accelerator-Data and Analytics Platform
The Critical Path Institute (C-Path) and the National Organization for Rare Disorders® (NORD) will host a meeting on Tuesday, September 17 in Bethesda, Maryland,...
Gamida Cell Presented Omidubicel Cell Therapy For Blood Cancers At ISCT Meeting In Melbourne
Two presentations on omidubicel (formerly known as NiCord®),
an investigational advanced cell therapy in Phase 3 clinical development
designed to enhance the life-saving benefits of hematopoietic...
Circuit Clinical™ Partners With CUBRC Applying Machine Learning To Predict Therapy Response
Circuit Clinical™, one of the USA's largest integrated research organizations dedicated to empowering patients to choose clinical research as a care option, has announced...
Basic Research And Treatment Strategies For Hereditary Aggrecan Deficiency Awarded
Recently, an international team of researchers received the
2019 Human Growth Award at the Pediatric Endocrine Society's Annual Meeting for
their abstract, entitled "Clinical Characterization and...
CloudLIMS Released Kits Module For Clinical Research And Testing Laboratories
CloudLIMS, a leading laboratory data management informatics provider, has announced the release of a Kits module for its Laboratory Information Management System (LIMS), CloudLIMS....
Cellect Prepared For US Clinical Trial
Cellect Biotechnology Ltd. has announced a collaboration with Washington University in St. Louis, Missouri, USA, in a U.S. Phase I/II study aimed at determining...
StemCyte Receives IND Clearance Of Mononuclear Stem Cells In Spinal Cord Injury Clinical Trials
On December 14, 2018, the U.S. Food and Drug Administration
(FDA), approved StemCyte’s Phase II Investigational New Drug (IND) application
for Allogeneic Human Leukocyte Antigen (HLA)-Matched...
Phase I/II Study Of Gamida Cell’s NiCord® Universal Bone Marrow Transplant Solution Published
Gamida Cell Ltd., a leading cellular and immune therapeutics company, has announced the publication of data from a multi-center Phase 1/2 clinical study evaluating...
ExCellThera Presented ECT-001 Enhanced Cord Blood Transplant For Patients With Blood Cancers At ASH
ExCellThera Inc., presented data on the company’s Phase I/II clinical trial using its lead technology, ECT-001, for allogeneic stem cell transplant at the 60th...
🔥 Popular Posts
10 Largest Biobanks in the World
Disclaimer: This article is not intended to be definitive. It was sourced from freely, openly available information on the internet. Due to the vastness...
📌 Recently Featured
Canada to Establish First National Multiple Myeloma Biobank With $6 Million Gift
Major philanthropic investment: An anonymous $6 million gift will support Canada's first national biobank dedicated exclusively to multiple myeloma research.
Research infrastructure: The...
